Your browser doesn't support javascript.
loading
Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial.
Heerspink, Hiddo J L; Birkenfeld, Andreas L; Cherney, David Z I; Colhoun, Helen M; Ji, Linong; Mathieu, Chantal; Groop, Per-Henrik; Pratley, Richard E; Rosas, Sylvia E; Rossing, Peter; Skyler, Jay S; Tuttle, Katherine R; Lawatscheck, Robert; Scott, Charlie; Edfors, Robert; Scheerer, Markus F; Kolkhof, Peter; McGill, Janet B.
Afiliação
  • Heerspink HJL; Clinical Pharmacy and Pharmacology, University of Groningen University Medical Centre Groningen, PO Box 30.001, 9700 RB Groningen, Netherlands. Electronic address: h.j.lambers.heerspink@umcg.nl.
  • Birkenfeld AL; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Otfried Müller Street 47, 72076 Tübingen, Germany; German Centre for Diabetes Research (DZD), Neuherberg, Germany; Department of Internal Medicine, Division of Endocrinology, Diabetol
  • Cherney DZI; Division of Nephrology, University Health Network, Toronto General Hospital, University of Toronto, 585 University Ave, 8N-845, Toronto, Ontario M5G 2N2, Canada.
  • Colhoun HM; Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.
  • Ji L; Departments of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Centre, No 11, Xizhimen South Street, Beijing 100044, China.
  • Mathieu C; Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.
  • Groop PH; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki (C318b), Haartmaninkatu 8, FIN-00290 Helsinki, Finland.
  • Pratley RE; AdventHealth Translational Research Institute, Orlando, FL 32804, USA.
  • Rosas SE; Kidney and Hypertension Unit, Joslin Diabetes Center, Harvard Medical School, One Joslin Place, Boston, MA 02215, USA.
  • Rossing P; Steno Diabetes Center Copenhagen, Borgmester Ib Juuls Vej 83, 2730 Herlev, Denmark; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N, Denmark.
  • Skyler JS; Department of Medicine, University of Miami, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Tuttle KR; Providence Inland Northwest Health, University of Washington School of Medicine, 105 W. 8th Avenue, Suite 250 E, Spokane, WA 99204, USA.
  • Lawatscheck R; Cardiology and Nephrology Clinical Research, Bayer AG, Research & Development, Pharmaceuticals, Clinical Development, Building S101, 13342 Berlin, Germany.
  • Scott C; Data Science and Analytics, Bayer PLC, Research & Development, Pharmaceuticals, 400 South Oak Way, Reading RG2 6AD, UK.
  • Edfors R; Cardiovascular Studies & Pipeline, Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer AG, Building S102, 13342 Berlin, Germany.
  • Scheerer MF; Medical Affairs & Pharmacovigilance, Pharmaceuticals, TA CardioRenal & Heart Disease, Bayer AG, Building S102, 04/160, 13353 Berlin, Germany.
  • Kolkhof P; Research and Development, Pharmaceuticals, Cardiovascular Precision Medicines, Bayer AG, 42113 Wuppertal, Germany.
  • McGill JB; Division of Endocrinology, Metabolism & Lipid Research, Washington University in St. Louis, School of Medicine, 660 S. Euclid, Campus Box 8127, St. Louis, MO 63110, USA.
Diabetes Res Clin Pract ; 204: 110908, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37805000

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal / Insuficiência Renal Crônica Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Insuficiência Renal / Insuficiência Renal Crônica Idioma: En Ano de publicação: 2023 Tipo de documento: Article